Old Web
English
Sign In
Acemap
>
authorDetail
>
Howida Shawki
Howida Shawki
Royal Liverpool University Hospital
Medicine
Pathology
Biomarker (medicine)
Renal cell carcinoma
Targeted therapy
4
Papers
120
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Hereditary haemochromatosis, haemophagocytic lymphohistiocytosis and COVID-19.
2020
Matthew J. Riley
Scott Rory Hicks
Sharon Irvine
Tom J. Blanchard
Edward Britton
Howida Shawki
Muhammad Sajid Pervaiz
Tom E. Fletcher
Show All
Source
Cite
Save
Citations (1)
Combined p53 and MDM2 biomarker analysis shows a unique pattern of expression associated with poor prognosis in patients with renal cell carcinoma undergoing radical nephrectomy.
2012
BJUI
Aidan P. Noon
Radosław Polański
A. El-Fert
Helen Kalirai
Howida Shawki
Fiona Campbell
A. Dodson
Richard Eccles
Bryony H. Lloyd
D R Sibson
Sarah E. Coupland
Sarah L. Lake
Keith Parsons
Nikolina Vlatković
Mark T. Boyd
Show All
Source
Cite
Save
Citations (30)
p53 and MDM2 in Renal Cell Carcinoma: Biomarkers for Disease Progression and Future Therapeutic Targets?
2010
Cancer
Aidan P. Noon
Nikolina Vlatković
Radosław Polański
Maria Maguire
Howida Shawki
Keith Parsons
Mark T. Boyd
Show All
Source
Cite
Save
Citations (85)
Membranous glomerulonephritis—an under-reported histological finding in multiple myeloma
2009
Nephrology Dialysis Transplantation
Jecko Thachil
Walid Sadik
Howida Shawki
Kottarathil A. Abraham
Show All
Source
Cite
Save
Citations (4)
1